HR logo

HEALTHCARE REALTY TRUST INC

HRNYSE
๐Ÿ† #1112 by market capEarnings Oct 29 ยท PostUS Equity
$17.78โ–ฒ $0.25 (+1.43%)
Latest quote
๐Ÿ””
Track HR
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ฒ 1.4%
7dโ–ผ 0.8%
14dโ–ฒ 2.3%
30dโ–ผ 0.9%
ytdโ–ฒ 4.9%
1yโ–ฒ 0.1%
๐ŸฆMarket Cap
$6.09B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
-6.3%
Declining
๐Ÿ“ŠGross Margin
63.0%
High
๐Ÿ’ตFCF Margin
11.7%
Healthy
โš–๏ธP/S Ratio
5.2x
Fair
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$17.59 โ€“ $17.80
52-Week Range
$16.31 โ€“ $22.04
Volume (shares)
99,730
Avg Volume (shares)
โ€”
Shares Outstanding
342.7M
Next Earnings
2026-10-29

Fundamentals Snapshot

Annual Revenue
โ€”
Last Q Revenue
โ€”
P/E Ratio
โ€”
P/S Ratio
5.2x
EPS (TTM)
$-0.25
Dividend Yield
5.61%
HR logo

HEALTHCARE REALTY TRUST INC

HR
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About HEALTHCARE REALTY TRUST INC

Healthcare Realty Trust operates as a Real Estate Investment Trust (REIT), specializing in the acquisition, development, financing, and active management of income-generating real estate assets, predominantly serving outpatient healthcare providers throughout the United States. By September 30, 2020, its extensive portfolio comprised 211 properties located across 24 states, collectively spanning 15.5 million square feet and valued at approximately $5.5 billion. The company further provided comprehensive leasing and property management solutions for 11.9 million square feet nationwide.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100

Analyst Ratings

โ“˜
Consensus
Buy
21 analysts
Strong Buy4
Buy7
Hold10
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.